Project Information

Unit Code

Financing Institution

Lead

Project Title

Search

Code	Project Title	Financing Institution	Lead	Year of Project Start
	The effectiveness of pleuran in treatment of acute gastroenteritis in children- a randomized, placebo- controlled, double- blind trial	NUTRICIA FOUNDATION	Joanna Seliga - Siwecka
	The effectiveness of pleuran in treatment of acute gastroenteritis in children - a randomized, placebo-controlled, double-blind trial	NUTRICIA FOUNDATION	dr hab. Ernest Kuchar
	Effect of a low-FODMAP diet for the management of irritable bowel syndrome in children: a randomized controlled trial	NUTRICIA FOUNDATION	dr hab. Andrea Horvath-Stolarczyk
	CureGN: Glomerulonephropathy Network.	National Institute of Health/University of Columbia	dr hab. n. med. Krzysztof Mucha
	Education of doctors in the field of vaccination of children with autism spectrum disorders	GlaxoSmithKline	lek. Anna Piwowarczyk
	Assessment of the safety and efficacy of an advanced therapy medicinal product containing living ASCs in the treatment of diabetic foot syndrome - a randomized, double-blind study (FootCell)	Medical Research Agency	prof. dr hab. n. med. Małgorzata Lewandowska-Szumieł
	Phase 2a non-commercial and non-randomized intervention study. evaluating the effectiveness of crizotinib in the treatment of children with severe form of neurofibromatosis type 2, in particular those who cannot undergo surgery and radiotherapy	Medical Research Agency	dr n. med. Marek Karwacki
	Assessment of the frequency of persistent pulmonary hypertension of newborns in the group of newborns born between 32nd and 42th week of pregnancy treated with salbutamol	Medical Research Agency	dr hab. n. med. Renata Bokiniec
	A multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of immunosuppression in biopsy-proven virus negative myocarditis or inflammatory cardiomyopathy (IMPROVE-MC)	Medical Research Agency	Kierownik Projektu - dr n. med. Krzysztof Ozierański, Główny Badacz - prof. dr hab. Marcin Grabowski
	Incidence of SARS-CoV-2 infections among police employees in Mazowieckie province - representative epidemiological study	Medical Research Agency	prof. dr hab. Mariusz Gujski
	Use of targeted therapy in children from 3 to 18 years of age with the diagnosis of diffuse intrinsic pontine glioma-DIPG based on the results of DIPGen genetic tests	Medical Research Agency	prof. dr hab. Rafał Płoski
	Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI)	Medical Research Agency	dr Aleksandra Gąsecka - van der Pol
	A multicentre, randomized, double-blind, placebo-controlled clinical trial evaluating the effect of intestinal microbiota transplantation as an inflammatory response modulator (immunomodulation), included in standard therapy	Medical Research Agency	dr n. med. Jarosław Biliński
	Evaluation of the efficacy and safety of empagliflozin in the treatment of neutropenia in patients with glycogenosis 1b "- EMPAtia	Medical Research Agency	dr Piotr Sobieraj
	Polish Chimeric Antigen Receptor T-cell Network	Medical Research Agency	dr hab. n. med. Radosław Zagożdżon (Kierownik Projektu) / prof. dr hab. Sebastian Giebel (Główny Badacz)
	Evaluation of the effect of fenofibrate on the function of pancreatic beta cells in children with newly diagnosed type 1 diabetes	Medical Research Agency	prof. dr hab. Agnieszka Szypowska
	The use of platelet-rich leukocyte fibrin as a stimulator of the angiogenesis process in patients undergoing revascularization due to critical ischemia of the lower limbs	Medical Research Agency	prof. dr hab. Zbigniew Gałązka
	Evaluation of the effectiveness of topical treatment with budesonide in children with Crohn's disease with localization in the esophagus and/or stomach and/or duodenum	Medical Research Agency	prof. dr hab. n. med. Aleksandra Banaszkiewicz
	Use of anti-CD19 CAR-T lymphocytes in the treatment of adult patients with relapsed and refractory acute lymphoblastic leukemia. Phase I / II clinical trial	Medical Research Agency	prof. dr hab. Grzegorz Basak
	Evaluation of the efficacy and safety of Nebivolol in the treatment of hypertension in adolescents	Medical Research Agency	dr hab. Małgorzata Pańczyk-Tomaszewska